Health Canada announces labeling update for statins
The update warns about the risk of increased blood sugar levels and an increased risk of diabetes among patients with pre-existing risk factors for diabetes including high levels
The US Food and Drug Administration (FDA) has declined to approve Unicycive Therapeutics’ resubmitted new drug application (NDA) for oxylanthanum carbonate (OLC) to treat hyperphosphatemia in chronic kidney disease (CKD) patients on dialysis.
BDSI claims that BNX, which uses BioErodible MucoAdhesive Technology (BEMA) and is formulated with naloxone to deliver buprenorphine for opioid dependence management, can be considered as an alternative
The acquisition will add BAC BV’s proprietary affinity ligands to Life Tech’s bioproduction portfolio of POROS chromatography resins, designed for purification of therapeutic products. Life Technologies bioproduction head